Condition

Multivessel Coronary Artery Disease

ClinicalTrials.gov condition label

Clinical trials4

Recruiting2

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)NCT07269366 · 2026-05-01

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCINCT07149714 · 2023-02-17

Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasENCT07602790 · 2026-11-01

NOT_YET_RECRUITING

Plasmonic Nanophotothermal Therapy of AtherosclerosisNCT01270139 · 2007-04-01

Common interventions

CABGPROCEDURE1 iVAC 2LDEVICE1 PCIPROCEDURE1 Renal denervationDEVICE1 StentingDEVICE1 Transplantation of iron-bearing nanoparticlesPROCEDURE1 Transplantation of nanoparticlesPROCEDURE1

Leading sponsors

Ceric Sàrl1 National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1 University Medical Center Groningen1 Ural State Medical University1

Trial status mix

RECRUITING2

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

NA4

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.